Related Experiment Video
Updated: Jul 4, 2026
09:44
Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
Apical junction complex proteins and ulcerative colitis: a focus on the PTPRS gene
1Department of Pediatrics, Division of Gastroenterology, Hepatology & Nutrition, Program in Cell Biology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada. aleixo.muise@sickkids.ca
Expert Review of Molecular Diagnostics
|July 5, 2008
Summary
Inflammatory bowel disease (IBD) genetics are complex. New research highlights apical junction complex proteins, including PTPRS, in ulcerative colitis pathogenesis, suggesting a primary barrier defense defect.
Area of Science:
- Gastroenterology and Genetics
- Molecular Biology and Immunology
Background:
- Inflammatory bowel disease (IBD) is a multifactorial condition with significant genetic underpinnings.
- Established genetic links for Crohn's disease involve innate immunity (NOD2), autophagy (ATG16L1), and Th17 pathways (IL23R).
- The genetic basis for ulcerative colitis (UC) remains less defined, though apical junction complex proteins are increasingly implicated.
Purpose of the Study:
- To review current genetic findings in IBD.
- To explore the role of apical junction complex proteins in UC pathogenesis.
- To highlight the PTPRS gene and its protein PTPsigma in UC.
Main Methods:
- Literature review of up-to-date studies on IBD genetics.
- Analysis of research implicating apical junction complex proteins in UC.
- Focus on the PTPRS gene and its contribution to barrier defense.
Main Results:
- Recent IBD genetic discoveries focus on NOD2, ATG16L1, and IL23R for Crohn's disease.
- Growing evidence suggests apical junction complex proteins are involved in UC.
- The PTPRS gene and its protein PTPsigma are identified as key players in UC pathogenesis.
Conclusions:
- UC pathogenesis may involve a primary defect in intestinal barrier defense.
- Apical junction complex proteins, particularly PTPRS, are critical in UC development.
- Further research into these proteins could reveal new therapeutic targets for UC.
Related Concept Videos
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Tight Junctions
Tight junctions are molecular seals between cells that prevent the leaking of fluids, ions, and other small solutes across cavities and compartments in multicellular organisms. They are mainly composed of claudin and occludin transmembrane proteins, and other proteins such as tricellulin and JAM (junctional adhesion molecule). All these proteins are 4-pass transmembrane proteins, except JAM, which is a single-pass transmembrane protein belonging to the immunoglobulin superfamily. The...